当前位置:首页 - 行情中心 - 康弘药业(002773) - 财务分析 - 现金流量表

康弘药业

(002773)

  

流通市值:134.35亿  总市值:180.21亿
流通股本:6.87亿   总股本:9.21亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,384,546,075.622,258,102,179.781,172,035,090.594,967,274,679.87
  收到的税费返还526,464.44451,348.16--
  收到其他与经营活动有关的现金61,985,861.9844,994,769.6820,849,109.98128,802,523.9
  经营活动现金流入小计3,447,058,402.042,303,548,297.621,192,884,200.575,096,077,203.77
  购买商品、接受劳务支付的现金263,692,905.9182,238,401.6583,183,428.62310,805,097.09
  支付给职工以及为职工支付的现金938,828,311.83643,498,847.78370,214,374.441,301,289,008.4
  支付的各项税费497,530,219.87336,339,829.22138,049,510.14434,846,130.68
  支付其他与经营活动有关的现金935,134,339.41601,699,478.6257,126,175.991,545,488,514.88
  经营活动现金流出小计2,635,185,777.011,763,776,557.25848,573,489.193,592,428,751.05
  经营活动产生的现金流量净额811,872,625.03539,771,740.37344,310,711.381,503,648,452.72
二、投资活动产生的现金流量:
  收回投资收到的现金1,555,000,0001,240,000,000-5,955,000,000
  取得投资收益收到的现金4,553,202.233,175,854.44-36,883,259.65
  处置固定资产、无形资产和其他长期资产收回的现金净额82,069.6135,872.6127,567.61214,808.09
  收到的其他与投资活动有关的现金690,000150,000-1,270,000
  投资活动现金流入小计1,560,325,271.841,243,361,727.0527,567.615,993,368,067.74
  购建固定资产、无形资产和其他长期资产支付的现金225,631,603.41144,521,989.569,554,905.95262,480,608.58
  投资支付的现金4,524,000,0004,159,000,000440,000,0005,955,000,000
  支付其他与投资活动有关的现金1,400,635.171,170,458.17200,0001,254,000
  投资活动现金流出小计4,751,032,238.584,304,692,447.67509,754,905.956,218,734,608.58
  投资活动产生的现金流量净额-3,190,706,966.74-3,061,330,720.62-509,727,338.34-225,366,540.84
三、筹资活动产生的现金流量:
  吸收投资收到的现金74,73674,736-35,067,485
  其中:子公司吸收少数股东投资收到的现金---1,830,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计74,73674,736-35,067,485
  分配股利、利润或偿付利息支付的现金644,928,447.8499,519,954.5-552,673,862.4
  支付其他与筹资活动有关的现金1,788,572.031,418,421.881,267,868.411,916,316.57
  筹资活动现金流出小计646,717,019.83500,938,376.381,267,868.41554,590,178.97
  筹资活动产生的现金流量净额-646,642,283.83-500,863,640.38-1,267,868.41-519,522,693.97
四、汇率变动对现金及现金等价物的影响-81,207.04-247,626.47-157,509.87-482,965.57
五、现金及现金等价物净增加额-3,025,557,832.58-3,022,670,247.1-166,842,005.24758,276,252.34
  加:期初现金及现金等价物余额6,383,703,498.96,383,703,498.96,383,703,498.95,625,427,246.56
  期末现金及现金等价物余额3,358,145,666.323,361,033,251.86,216,861,493.666,383,703,498.9
补充资料:
  净利润-554,945,878.85-1,145,503,613.71
  资产减值准备-4,461,778.68-7,985,713.08
  固定资产和投资性房地产折旧-104,601,471.74-199,296,374.84
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-104,601,471.74-199,296,374.84
  无形资产摊销-19,933,546.36-37,074,895.78
  长期待摊费用摊销-286,025.53-5,789,209.17
  处置固定资产、无形资产和其他长期资产的损失-61,057.22--9,782.42
  固定资产报废损失-836,898.7-598,226.96
  公允价值变动损失--1,569,600--550,600
  财务费用-279,447.91-402,269.43
  投资损失--8,361,729.37--36,236,443.63
  递延所得税-26,919,080.8-127,152,034.56
  其中:递延所得税资产减少-25,837,465.95-130,605,127.48
    递延所得税负债增加-1,081,614.85--3,453,092.92
  存货的减少-1,837,626--22,160,586.1
  经营性应收项目的减少--167,202,874.93--3,007,100.78
  经营性应付项目的增加-3,971,477.02-37,988,875.41
  其他--2,088,585.13-2,052,907.36
  现金的期末余额-3,361,033,251.8-6,383,703,498.9
  减:现金的期初余额-6,383,703,498.9-5,625,427,246.56
  现金及现金等价物的净增加额--3,022,670,247.1-758,276,252.34
公告日期2026-10-282026-08-262026-04-232026-04-23
审计意见(境内)标准无保留意见
TOP↑